Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Geethakumari PR"'
Autor:
Grover NS; Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Annunzio K; Divsion of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Watkins M; Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Torka P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Karmali R; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Anampa-Guzmán A; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA., Oh TS; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Reves H; Section of Hematologic Malignancies and Cellular Therapy, Division of Hematology-Oncology, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Tavakkoli M; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hansinger E; Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA., Christian B; Divsion of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Thomas C; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA., Barta SK; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Geethakumari PR; Section of Hematologic Malignancies and Cellular Therapy, Division of Hematology-Oncology, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Bartlett NL; Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Shouse G; Department of Medicine, City of Hope National Medical Center, Duarte, CA, USA., Olszewski AJ; Department of Medicine, Brown University, Providence, RI, USA., Epperla N; Divsion of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. naren.epperla@hci.utah.edu.; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. naren.epperla@hci.utah.edu.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Oct 18; Vol. 14 (1), pp. 182. Date of Electronic Publication: 2024 Oct 18.
Autor:
Mercadal S; Utah Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., Allbee-Johnson M; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., Ganguly S; Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY; Section of Hematology, Houston Methodist Hospital and Neal Cancer Center, Houston, TX., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Hong S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC., Malone A; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY., Murthy H; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL., Pawarode A; Division of Hematology/Oncology, Department of Internal Medicine, Blood and Marrow Transplantation Program, University of Michigan Medical School, Ann Arbor, MI., Sica AR; Department of Hematology-Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY., Solh M; Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA., Ustun C; Rush University Medical Center, Chicago, IL., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Sauter CS; Hematology/Medical Oncology, Cleveland Clinic, Cleveland, OH., Hamadani M; BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI. mhamadani@mcw.edu., Herrera AF; City of Hope, Duarte, CA., Lee CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v:
Haematologica [Haematologica] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.
Autor:
Epperla N; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH., Zhao Q; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH., Karmali R; Department of Medicine, Northwestern University, Chicago, IL., Torka P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shea L; Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO., Oh TS; Department of Medicine, Northwestern University, Chicago, IL., Anampa-Guzmán A; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY., Reves H; Department of Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX., Tavakkoli M; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Greenwell IB; Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC., Hansinger E; Department of Medicine, Thomas Jefferson University, Philadelphia, PA., Umyarova E; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH.; Department of Medicine, University of Vermont, Burlington, VT., Annunzio K; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH., Sawalha Y; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH., Christian B; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH., Thomas C; Department of Medicine, Thomas Jefferson University, Philadelphia, PA., Barta SK; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Geethakumari PR; Department of Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX., Bartlett NL; Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO., Grover NS; Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Olszewski AJ; Department of Medicine, Brown University, Providence, RI.
Publikováno v:
Blood advances [Blood Adv] 2023 Sep 12; Vol. 7 (17), pp. 5038-5046.
Autor:
Chavez JC; Moffitt Cancer Center, Tampa, Florida., Foss FM; Hematology, Yale Cancer Center, New Haven, Connecticut., William BM; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Brammer JE; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Smith SM; University of Chicago, Chicago, Illinois., Prica A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Zain JM; City of Hope Comprehensive Cancer Center, Duarte, California., Tuscano JM; UC Davis Cancer Center, Sacramento, California., Shah H; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Mehta-Shah N; Siteman Cancer Center, Washington University, St. Louis, Missouri., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas., Wang BX; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Zantinge S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Wang L; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Zhang L; Department of Hematopathology, Moffitt Cancer Center, Tampa, Florida., Boutrin A; US Imaging Hub, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, Maryland., Zhao W; US Imaging Hub, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, Maryland., Cheng L; Oncology Safety/Pathology, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, Maryland., Standifer N; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, South San Francisco, California., Hewitt L; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland., Enowtambong E; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland., Shao W; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland., Sharma S; Quantitative Clinical Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, South San Francisco, California., Carlesso G; Early Oncology Discovery, Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Moscow JA; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 May 15; Vol. 29 (10), pp. 1869-1878.
Autor:
Epperla N; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA. Narendranath.Epperla@osumc.edu., Welkie RL; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA., Torka P; Roswell Park Cancer Institute, Buffalo, NY, USA., Shouse G; City of Hope, Duarte, CA, USA., Karmali R; Northwestern University, Chicago, IL, USA., Shea L; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Anampa-Guzmán A; Roswell Park Cancer Institute, Buffalo, NY, USA., Oh TS; Northwestern University, Chicago, IL, USA., Reaves H; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Tavakkoli M; University of Pennsylvania, Philadelphia, PA, USA., Lindsey K; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Greenwell IB; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Hansinger E; Thomas Jefferson University, Philadelphia, PA, USA., Thomas C; Thomas Jefferson University, Philadelphia, PA, USA., Chowdhury SM; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA., Annunzio K; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA., Christian B; Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA., Barta SK; University of Pennsylvania, Philadelphia, PA, USA., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Herrera AF; City of Hope, Duarte, CA, USA., Grover NS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Olszewski AJ; Brown University, Providence, RI, USA.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2023 May 08; Vol. 16 (1), pp. 49. Date of Electronic Publication: 2023 May 08.
Autor:
Hoff FW; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Chung SS; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Patel PA; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Premnath N; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Khatib J; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Tadic-Ovcina M; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., AhmedRabie A; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Helton D; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Yohannes S; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Shahan J; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Patel H; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Vusirikala M; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Collins RH; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America., Madanat YF; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States of America. Electronic address: yazan.madanat@utsouthwestern.edu.
Publikováno v:
Transplant immunology [Transpl Immunol] 2023 Apr; Vol. 77, pp. 101808. Date of Electronic Publication: 2023 Feb 24.
Autor:
Hoff FW; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Goksu SY; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Premnath N; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Patel PA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Ikpefan R; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Kaur G; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Vusirikala M; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Bat T; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Chen W; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Anderson LD Jr; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Awan FT; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Collins RH; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Weinberg OK; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX., Muthukumar A; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX., Chung SS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA., Madanat YF; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA. yazan.madanat@utsouthwestern.edu.
Publikováno v:
Acta medica academica [Acta Med Acad] 2023 Apr; Vol. 52 (1), pp. 30-36.
Optimizing Palliative Focal Radiation Therapy Dose in Cutaneous T-Cell Lymphoma: How Low Can You Go?
Autor:
Patel AM; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., West L; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas., Atluri PS; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Yi SF; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Rizvi S; Department of Medical Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Geethakumari PR; Department of Medical Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Awan FT; Department of Medical Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Chen W; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas., Shah JL; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Desai NB; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Goff HW; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas., Kumar KA; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: kiran.kumar@utsouthwestern.edu.
Publikováno v:
Practical radiation oncology [Pract Radiat Oncol] 2023 Mar-Apr; Vol. 13 (2), pp. e192-e199. Date of Electronic Publication: 2022 Oct 25.
Autor:
Premnath N; Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address: naveen.premnath@utsouthwestern.edu., Chung SS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States; Children's Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States., Weinberg OK; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Ikpefan R; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Pandey M; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Kaur G; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Afrough A; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Awan FT; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Anderson LD Jr; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Vusirikala M; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Collins RH; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Chen W; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Agathocleous M; Children's Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States., Madanat YF; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Publikováno v:
Leukemia research [Leuk Res] 2023 Feb; Vol. 125, pp. 107001. Date of Electronic Publication: 2022 Dec 21.
Autor:
Epperla N; Division of Hematology, The Ohio State University, Columbus, OH., Zhao Q; Division of Hematology, The Ohio State University, Columbus, OH., Chowdhury SM; Division of Hematology, The Ohio State University, Columbus, OH., Shea L; Division of Hematology, Washington University, St. Louis, MO., Moyo TK; Levine Cancer Center, Atrium Health, Charlotte, NC., Reddy N; Vanderbilt University Medical Center, Nashville, TN., Sheets J; Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC., Weiner DM; Division of Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Kandarpa M; Division of Hematology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Bruno XJ; Division of Hematology and Oncology, University of Vermont, Burlington, VT., Thomas C; Division of Hematology, Thomas Jefferson University, Philadelphia, PA., Churnetski MC; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA., Hsu A; Division of Hematology, Brown University, Providence, RI., Zurbriggen L; Division of Hematology, University of Wisconsin, Madison, WI., Tan XC; Cancer Institute of New Jersey, New Brunswick, NJ., Lindsey K; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC., Maakaron J; Division of Hematology, University of Minnesota, Minneapolis, MN., Caimi PF; University Hospitals Seidman Cancer Center, Cleveland, OH., Torka P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY., Bello C; Division of Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Ayyappan S; Division of Hematology and Oncology, University of Iowa, Iowa City, IA., Oh TS; Division of Hematology, Northwestern University, Chicago, IL., Karmali R; Division of Hematology, Northwestern University, Chicago, IL., Kim SH; Division of Hematology and Oncology, Rush University, Chicago, IL., Kress A; Division of Hematology, Yale University, New Haven, CT., Kothari S; Division of Hematology, Yale University, New Haven, CT., Sawalha Y; Division of Hematology, The Ohio State University, Columbus, OH., Christian B; Division of Hematology, The Ohio State University, Columbus, OH., David KA; Cancer Institute of New Jersey, New Brunswick, NJ., Greenwell IB; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC., Janakiram M; Division of Hematology, University of Minnesota, Minneapolis, MN., Kenkre VP; Division of Hematology, University of Wisconsin, Madison, WI., Olszewski AJ; Division of Hematology, Brown University, Providence, RI., Cohen JB; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA., Palmisiano N; Division of Hematology, Thomas Jefferson University, Philadelphia, PA., Umyarova E; Division of Hematology and Oncology, University of Vermont, Burlington, VT., Wilcox RA; Division of Hematology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Awan FT; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Alderuccio JP; Division of Hematology, University of Miami, Miami, FL., Barta SK; Division of Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Grover NS; Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC., Ghosh N; Levine Cancer Center, Atrium Health, Charlotte, NC., Bartlett NL; Division of Hematology, Washington University, St. Louis, MO., Herrera AF; Division of Hematology, City of Hope, Duarte, CA., Shouse G; Division of Hematology, City of Hope, Duarte, CA.
Publikováno v:
Blood advances [Blood Adv] 2023 Jan 10; Vol. 7 (1), pp. 88-91.